Non-Invasive "Metabolic Profiling" of Embryos Predicts First-Trimester Miscarriage Risk

Written By camellia chen

【Abstract】: (Scientific Publication) A study in The Lancet Digital Health reveals that analyzing the "metabolic waste products" (amino acids and pyruvate) in the culture media can predict not just implantation, but the likelihood of miscarriage after implantation with 88% accuracy. This "Metabolomic Score" adds a crucial layer of safety beyond genetic testing.

  • Business Insight: The industry is moving from "Getting Pregnant" to "Staying Pregnant." Miscarriage is the most traumatic event for patients; a test that mitigates this risk has immense commercial value. This technology (likely software + mass spectrometry service) will become a standard "Risk Management" add-on for patients with a history of recurrent pregnancy loss.

  • 【Keywords】: #Metabolomics #MiscarriagePrevention #PrecisionMedicine

  • 【Source】: The Lancet Digital Health (Feb 15, 2026)

camellia chen
Previous

NHC Removes "Population-Based" Quotas for IVF Licenses in New 5-Year Plan
Next

European Market: Greece and Portugal See 45% Rise in IVF Cycles from Chinese "Golden Visa" Holders